OpenURL Connection Search

Select item for more details and to access through your institution.

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
Published in:
2018
By:
- Hirsh, Vera;
- Yin Wan;
- Fang-Ju Lin;
- Margunato-Debay, Sandra;
- Teng Jin Ong;
- Wan, Yin;
- Lin, Fang-Ju;
- Ong, Teng Jin;
- Botteman, Marc;
- Langer, Corey
Publication type:
journal article
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Published in:
2021
By:
- Spigel, David R.;
- Jotte, Robert M.;
- Aix, Santiago Ponce;
- Gressot, Laurent;
- Morgensztern, Daniel;
- McCleod, Michael;
- Socinski, Mark A.;
- Daniel, Davey;
- Juan-Vidal, Oscar;
- Mileham, Kathryn F.;
- West, Howard;
- Page, Ray;
- Reinmuth, Niels;
- Knoble, Jeanna;
- Chen, Tianlei;
- Bhore, Rafia;
- Wolfsteiner, Marianne;
- Ong, Teng Jin;
- Gridelli, Cesare;
- Thomas, Michael
Publication type:
journal article
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.
Published in:
Lung Cancer: Targets & Therapy, 2017, v. 8, p. 207, doi. 10.2147/LCTT.S138570
By:
- Thomas, Michael;
- Spigel, David R.;
- Jotte, Robert M.;
- McCleod, Michael;
- Socinski, Mark A.;
- Page, Ray D.;
- Gressot, Laurent;
- Knoble, Jeanna;
- Juan, Oscar;
- Morgensztern, Daniel;
- Isla, Dolores;
- Kim, Edward S.;
- West, Howard;
- Ko, Amy;
- Teng Jin Ong;
- Trunova, Nataliya;
- Gridelli, Cesare
Publication type:
Article
nab -Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).
Published in:
Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.569715
By:
- Morgensztern, Daniel;
- Dols, Manuel Cobo;
- Ponce Aix, Santiago;
- Postmus, Pieter E.;
- Bennouna, Jaafar;
- Fischer, Jürgen R.;
- Juan-Vidal, Oscar;
- Stewart, David J.;
- Ardizzoni, Andrea;
- Bhore, Rafia;
- Wolfsteiner, Marianne;
- Reck, Martin;
- Talbot, Denis;
- Govindan, Ramaswamy;
- Ong, Teng Jin
Publication type:
Article
nab -Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis.
Published in:
Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.485587
By:
- Langer, Corey J.;
- Gajra, Ajeet;
- Gridelli, Cesare;
- Konduri, Kartik;
- Morgensztern, Daniel;
- Spigel, David;
- Talbot, Denis;
- Thomas, Michael;
- Weiss, Jared;
- Pilot, Richard;
- Bhore, Rafia;
- Wolfsteiner, Marianne;
- Ong, Teng Jin;
- Socinski, Mark
Publication type:
Article
nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2.
Published in:
Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00253
By:
- Gajra, Ajeet;
- Karim, Nagla Abdel;
- Mulford, Deborah A.;
- Villaruz, Liza Cosca;
- Matrana, Marc Ryan;
- Ali, Haythem Y.;
- Santos, Edgardo S.;
- Berry, Tymara;
- Ong, Teng Jin;
- Sanford, Alexandra;
- Amiri, Katayoun;
- Spigel, David R.
Publication type:
Article
nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial.
Published in:
Drug Design, Development & Therapy, 2018, v. 12, p. 1445, doi. 10.2147/DDDT.S155750
By:
- Gridelli, Cesare;
- Chen, Tianlei;
- Ko, Amy;
- O'Brien, Mary E;
- Ong, Teng Jin;
- Socinski, Mark A;
- Postmus, Pieter E
Publication type:
Article
Association between depth of response and survival in patients with advanced‐stage non–small cell lung cancer treated with first‐line chemotherapy.
Published in:
Cancer (0008543X), 2019, v. 125, n. 14, p. 2394, doi. 10.1002/cncr.32114
By:
- Morgensztern, Daniel;
- Ko, Amy;
- O'Brien, Mary;
- Ong, Teng Jin;
- Waqar, Saiama N.;
- Socinski, Mark A.;
- Postmus, Pieter E.;
- Bhore, Rafia
Publication type:
Article
Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy.
Published in:
2019
By:
- Morgensztern, Daniel;
- Ko, Amy;
- O'Brien, Mary;
- Ong, Teng Jin;
- Waqar, Saiama N;
- Socinski, Mark A;
- Postmus, Pieter E;
- Bhore, Rafia
Publication type:
journal article
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Published in:
2018
By:
- Morgensztern, Daniel;
- Cobo, Manuel;
- Ponce Aix, Santiago;
- Postmus, Pieter E.;
- Lewanski, Conrad R.;
- Bennouna, Jaafar;
- Fischer, Jürgen R.;
- Juan‐Vidal, Oscar;
- Stewart, David J.;
- Fasola, Gianpiero;
- Ardizzoni, Andrea;
- Bhore, Rafia;
- Wolfsteiner, Marianne;
- Talbot, Denis C.;
- Jin Ong, Teng;
- Govindan, Ramaswamy;
- on behalf of the ABOUND.2L+ Investigators;
- Juan-Vidal, Oscar;
- On Behalf Of The Abound L Investigators
Publication type:
journal article
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab -Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01256
By:
- Goldman, Jonathan W.;
- Waterhouse, David M.;
- George, Ben;
- O'Dwyer, Peter J.;
- Bhore, Rafia;
- Banerjee, Sibabrata;
- Lyons, Larry;
- Louis, Chrystal U.;
- Ong, Teng Jin;
- Kelly, Karen
Publication type:
Article

Found: 11